Syros Pharmaceuticals (SYRS) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

SYRS is expected to report earnings to rise 22.03% to -72 cents per share on November 12

Syros Pharmaceuticals SYRS Stock Earnings Reports

Q3'24

Est.

$-0.72

Q2'24

Beat

by $0.18

Q1'24

Beat

by $0.75

Q4'23

Est.

$-2.18

Q3'23

Missed

by $0.29

The last earnings report on July 31 showed earnings per share of -58 cents, beating the estimate of -76 cents. With 131.06K shares outstanding, the current market capitalization sits at 53.62M.

View a ticker or compare two or three

Compare

SYRS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For SYRS
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a therapeutics company focusing on discovering and developing novel gene control therapies

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

35 CambridgePark Drive

Phone

+1 617 744-1340

Employees

Web

https://www.syros.com